Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

New application of curcumin

A technology of curcumin and demethoxycurcumin, which is applied in the field of curcumin, can solve the problems of limited application of organ toxicity, adverse consequences, and acid-base balance disruption

Active Publication Date: 2013-01-23
CHINA PHARM UNIV
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But the organ toxicity of CsA limits its application in this area
④ Alkalinize the intestinal juice by oral alkaline preparations (such as sodium bicarbonate, magnesium oxide, alkaline water, etc.), so that the SN-38 lactone type (active type) moves to the carboxylic acid type (inactive type), reducing the lactone type The intestinal concentration of SN38 reduces the absorption of intestinal SN-38 (the intestinal absorption rate of lactone SN-38 is 10 times that of carboxylic acid type), exerts the therapeutic effect of delayed diarrhea, but long-term use may cause the acid-base balance in the body to be broken , with adverse consequences
[0016] 6. There is currently no report of curcumin being used to prevent or / and treat irinotecan-induced delayed diarrhea

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New application of curcumin
  • New application of curcumin
  • New application of curcumin

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0026] The above-mentioned content of the present invention will be described in further detail below through specific embodiments in the form of examples, but it should not be understood that the scope of the above-mentioned theme of the present invention is limited to the following examples. All technologies realized based on the above contents of the present invention belong to the scope of the present invention.

[0027] The therapeutic effect of embodiment curcumin on delayed diarrhea caused by irinotecan

[0028] 1. Experimental method

[0029] On the basis of the pre-test, 32 ICR male mice were randomly divided into 4 groups, with 8 mice in each group, and each mouse was housed in a single cage, with free access to food and water. The model group was intraperitoneally injected irinotecan 75mg / kg every day for four consecutive days; the curcumin group was intraperitoneally injected irinotecan 75mg / kg every day for four consecutive days, and at the same time intragastric...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides application of a curcumin on preparation of a medicine for preventing or / and treating a late diarrhea caused by an anti-tumor medicine, wherein the anti-tumor medicine is irinotecan or an active metabolite 7-thyl-10-hydroxycamptothecine (SN-38), and the late diarrhea is a severe diarrhea capable of lasting for 7 days appeared after the irinotecan is administrated for 24 hours. The curcumin provided by the invention is definite in efficacy; and with the adoption of the curcumin, the late diarrhea can be effectively relieved and the intestinal mucosa is protected.

Description

technical field [0001] The present invention relates to a new application of curcumin, in particular, the application in preventing or / and treating delayed diarrhea caused by antineoplastic drug irinotecan. Background technique [0002] Irinotecan (CPT-11 for short) is an antineoplastic drug widely used in clinical practice. It selectively inhibits topoisomerase I to exert cytotoxic effect. It is used for the first-line treatment of recurrence and deterioration of metastatic colorectal cancer after chemotherapy. This product can also be used alone or in combination with other drugs to treat small cell lung cancer, non-small cell lung cancer, malignant brain tumors, gastric cancer, pancreatic cancer, cervical cancer, ovarian cancer, etc. But the diarrhea (especially delayed diarrhea) caused by irinotecan seriously affects its clinical application. [0003] Diarrhea caused by irinotecan is divided into acute diarrhea and delayed diarrhea. Acute diarrhea mainly occurs within ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/12A61P1/12
Inventor 栾立标吴炎
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com